[ad_1] Purdue Pharma, the maker of OxyContin, has received a patent aimed at treating opioid dependence. The patent, first published by the Financial Times, concerns a new form of buprenorphine with faster …
Read More »
[ad_1] Top Local Stories KNOXVILLE, Tennessee (WATE) – The new crackdown on painkillers will begin in just under four months. BlueCross BlueShield, of Tennessee, announced on Thursday that it would no longer …
Read More »
[ad_1] DENVER, CO – The Colorado Attorney General's Office has taken legal action against prescription opioid manufacturers, claiming that it has been conducting fraudulent and deceptive marketing campaigns in recent decades. Attorney …
Read More »
[ad_1] If you have BlueCross BlueShield, the coverage of your prescription changes. The insurance company will no longer cover the costs of OxyContin. This new policy begins on January 1, 2019. If …
Read More »
[ad_1] A company whose prescription opioid marketing practices are accused of triggering the drug and overdose crisis said it was helping to fund an antidote for overdoses at a lower cost. The …
Read More »
[ad_1] CLOSE In an effort to combat the growing epidemic of prescription drugs and heroin abuse, the FBI and the DEA released "Chasing the Dragon: The Life of 39, an opiate addict, …
Read More »
[ad_1] Minnesota sues Purdue Pharma, the maker of narcotic analgesic OxyContin, as a result of a lengthy investigation into its commercialization and other tactics that allegedly contributed to an increasing number of …
Read More »